Latest news with #LadenburgThalmann
Business Upturn
11 hours ago
- Business
- Business Upturn
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
Live video webcast on Thursday, August 21 st at 1:00 PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) ('Autonomix' or the 'Company'), a medical device company focused on advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer will participate in a virtual investor webinar hosted by Ladenburg Thalmann on Thursday, August 21, 2025 and 1:00 PM ET. The webinar will be moderated by Jeffrey S. Cohen, Managing Director and Director of Equity Research of Ladenburg Thalmann. Following the discussion, there will be a question and answer session. Interested participants may pre-submit questions to [email protected] ahead of the event. To register for the webinar, please click here. The webinar will also be accessible on the Events page in the Investors section of the Company's website ( About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. For more information, visit and connect with the Company on X, LinkedIn, Instagram and Facebook. Investor and Media Contact JTC Team, LLCJenene Thomas (908) 824-0775 [email protected]
Yahoo
13 hours ago
- Business
- Yahoo
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
Live video webcast on Thursday, August 21st at 1:00 PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ('Autonomix' or the 'Company'), a medical device company focused on advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer will participate in a virtual investor webinar hosted by Ladenburg Thalmann on Thursday, August 21, 2025 and 1:00 PM ET. The webinar will be moderated by Jeffrey S. Cohen, Managing Director and Director of Equity Research of Ladenburg Thalmann. Following the discussion, there will be a question and answer session. Interested participants may pre-submit questions to events@ ahead of the event. To register for the webinar, please click here. The webinar will also be accessible on the Events page in the Investors section of the Company's website ( About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. For more information, visit and connect with the Company on X, LinkedIn, Instagram and Facebook. Investor and Media Contact JTC Team, LLCJenene Thomas (908) 824-0775autonomix@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
a day ago
- Business
- Yahoo
SoundHound (SOUN) Upgraded to ‘Buy' by Ladenburg After Strong Q2 and Amelia Acquisition
SoundHound AI (NASDAQ:SOUN) is one of the SoundHound AI (NASDAQ:SOUN) is one of the best midcap AI stocks to buy right now. On August 11, 2025, Ladenburg Thalmann upgraded SoundHound from Neutral to Buy and raised its price target from $9 to $16. The upgrade followed strong Q2 results and renewed confidence in the company's long-term trajectory. The analyst cited momentum across multiple segments, including enterprise voice AI, automotive integrations, and restaurant partnerships. They also noted that the recent acquisition of Amelia has expanded SoundHound's capabilities in conversational AI, while the launch of Vision AI adds another layer to its platform differentiation. Copyright: natashamam / 123RF Stock Photo Ladenburg expects SoundHound to generate over $270 million in revenue by 2027 and achieve double-digit adjusted EBITDA margins. While they acknowledge the company's 22x EV/revenue multiple as elevated, they believe the upside potential outweighs valuation concerns. The firm pointed to improving revenue visibility, expanding deal flow, and increased demand for AI-native solutions as strong tailwinds going forward. SoundHound AI is a California-based voice AI company that builds natural language understanding and speech recognition platforms for businesses. Its technology is deployed across industries including automotive, restaurants, and customer service, enabling users to interact with systems through voice and vision interfaces. While we acknowledge the potential of SOUN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and .
Yahoo
4 days ago
- Business
- Yahoo
Why SoundHound AI's (SOUN) Amelia Acquisition Could Pay Off in the Long Run
SoundHound AI, Inc. (NASDAQ:SOUN) is one of the AI Stocks Analysts Are Watching Closely. On August 11, Ladenburg Thalmann analyst Glenn Mattson upgraded the stock from Neutral to Buy with a price target of $16.00 (from $9.00). The rating upgrade comes after Soundhound posted second-quarter revenue well above expectations driven by its large contract wins. According to the firm, momentum in core verticals is helping offset previous concerns about low-margin contracts from the Amelia acquisition. These are anticipated to be phased out over the next 18 months. The firm also believes that SoundHound is building a broader platform that may link automotive, restaurant and enterprise customers into a voice-enabled ecosystem. This will in turn create lead-generation revenue streams. A Wall Street analyst reviewing stock information on a computer, examining data points for a new investment opportunity. 'We upgrade shares to Buy and raise our PT to $16 (from $9). We continue to view Voice as one of the key early applications for AI systems. The company is a leader in this space and is adding significant utility for enterprises looking to adopt AI functionality. The Amelia acquisition still needs further integration but is providing solid benefits in terms of scale, new lead generation, and an entry into the enterprise. While valuation remains elevated, the growth and scale justify that premium, in our view. We now use a 22x multiple on our new 2027 estimate to achieve our $16 PT. This is justified by the rule of 40 peer set found in the body of the report.' SoundHound AI, Inc. (NASDAQ:SOUN) is a voice artificial intelligence company offering voice AI solutions to businesses. While we acknowledge the potential of SOUN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Business
- Yahoo
SoundHound AI (SOUN) Surges 17.34% on Rating, Price Upgrade
We recently published . SoundHound AI Inc. (NASDAQ:SOUN) is one of the best-performing stocks on Monday. SoundHound AI soared by 17.34 percent on Monday to end at $15.9 apiece as investors took path from an investment firm's upgraded rating for its stock. In a market note, Ladenburg Thalmann raised SoundHound AI Inc. (NASDAQ:SOUN) to 'buy' from 'neutral' previously, alongside a higher price target of $16, as compared with the $9 prior. According to Ladenburg, the upgrade was based on SoundHound AI Inc.'s (NASDAQ:SOUN) increasing deals in the automotive sector that 'can give potential upside opportunity.' 'The penetration in Autos is growing as the company recently announced three major automotive brands in the US have rolled out with SOUN Chat AI embedded. This product drives user engagement and helps establish tech leadership in an increasingly competitive space … Management has pegged in-car commerce opportunity for OEMs at $35 billion annually,' it said. In an updated report, SoundHound AI, Inc. (NASDAQ:SOUN) said it narrowed its non-GAAP net loss in the second quarter of the year by 20 percent to $11.86 million from $14.89 million in the same period last year, but widened its GAAP net loss by 100 percent to $78 million from $37 million year-on-year. Revenues, on the other hand, soared by 217 percent to $42.68 million from only $13.46 million in the same period last year. SoundHound AI, Inc. (NASDAQ:SOUN) raised its full-year revenue growth outlook to a range of $160 million to $178 million, from the previous forecast of $156 million to $177 million. While we acknowledge the potential of SOUN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
